NextCure
Stock Forecast, Prediction & Price Target
NextCure Financial Estimates
NextCure Revenue Estimates
NextCure EBITDA Estimates
NextCure Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $3.3M Low: $3.3M High: $3.3M avg. 0% | Avg: $7M Low: $7M High: $7M avg. 112.12% | Avg: $40.5M Low: $40.5M High: $40.5M avg. 478.57% |
Net Income
% change YoY
| $-69.38M N/A | $-69.43M -0.06% | $-62.72M 9.66% | Avg: $-50.30M Low: $-56.50M High: $-39.24M avg. 19.79% | Avg: $-59.28M Low: $-27.83M High: $-26.44M avg. -17.83% | Avg: $-20.04M Low: $-20.04M High: $-20.04M avg. 66.19% | Avg: $-14.19M Low: $-14.19M High: $-14.19M avg. 29.16% |
EBITDA
% change YoY
| $-63.56M N/A | $-75.90M -19.41% | $-59.03M 22.22% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $659.99K Low: $659.99K High: $659.99K avg. 0% | Avg: $1.39M Low: $1.39M High: $1.39M avg. 112.12% | Avg: $8.09M Low: $8.09M High: $8.09M avg. 478.57% |
EPS
% change YoY
| -$2.51 N/A | -$2.5 0.39% | -$2.25 10% | Avg: -$1.69 Low: -$2.03 High: -$1.41 avg. 25.11% | Avg: -$0.98 Low: -$1 High: -$0.95 avg. 42.13% | Avg: -$0.72 Low: -$0.72 High: -$0.72 avg. 26.15% | Avg: -$0.51 Low: -$0.51 High: -$0.51 avg. 29.16% |
Operating Expenses
% change YoY
| $70.76M N/A | $75.90M 7.26% | $67.63M -10.89% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $3.48M Low: $3.48M High: $3.48M avg. 0% | Avg: $7.38M Low: $7.38M High: $7.38M avg. 112.12% | Avg: $42.73M Low: $42.73M High: $42.73M avg. 478.57% |
FAQ
What is NextCure stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 24.32% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -56.50M, average is -50.30M and high is -39.24M.
What is NextCure stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 147.67% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is NextCure stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 30.64% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$2.03, average is -$1.69 and high is $-1.41.
What is the best performing analyst?
In the last twelve months analysts have been covering NextCure stock. The most successful analyst is Edward Tenthoff.